Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AndroGel for Pain in Men with Opioid-Induced Hypogonadism
NCT00351819Phase 2Completed
- Sponsor
- Boston University
- Start
- Apr 2006
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Hypogonadism comparing Androgel (testosterone gel) with Placebo (2 arms). Primary endpoints: Brief Pain Inventory at 14 weeks, Algometer-induced Pressure Pain at 14 weeks and 2 more. Started Apr 2006; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00351819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351819.